A recent study underscored a potential role for Bcl2 family proteins in determining nelarabine resistance, in an Ara-G-resistant T-ALL cell line variant, established by serial incubation with Ara-G (the active metabolite of nelarabine) [27]. This evidence concerns the gene BCL2 and acute lymphoblastic leukemia.